21 results on '"Choi X"'
Search Results
2. A Review of CO2-Enhanced Oil Recovery with a Simulated Sensitivity Analysis
- Author
-
Perera, MSA, Gamage, RP, Rathnaweera, TD, Ranathunga, AS, Koay, A, Choi, X, Perera, MSA, Gamage, RP, Rathnaweera, TD, Ranathunga, AS, Koay, A, and Choi, X
- Published
- 2016
3. Study of the Mechanisms of Coal and Gas Outbursts Using a New Numerical Modeling Approach
- Author
-
Choi, X., Wold, M., Choi, X., and Wold, M.
- Abstract
During mining or roadway development, the distribution of stress and pore pressure in the coal face and rib around the new opening will change. These changes are usually dependent on the mining history and are related to the rate of roadway development, geometry of the opening, the pre-mining stress and reservoir conditions, the strength of the coal, the adjacent rock strata and major geological structures, and the permeability of the coal. Quasi-static yielding of coal is usually observed at regions of high stress concentration. However, under certain conditions, dynamic failure of coal in the form of an outburst can occur. The occurrence of coal and gas outbursts and the way they evolve will depend on a number of factors and processes. Under varied mining conditions, some of the factors and/or processes may play a more important role in outburst initiation than others. It can be misleading to attribute the cause of an outburst to a particular factor or process. This is partly because some of the processes are highly non-linear; outburst occurrence may depend on how these processes evolve and interact. The problem becomes more complex because natural heterogeneity of the coal and geological structures also play an important part in the outburst mechanisms.
- Published
- 2004
4. A Simplified Analytical Model for Desiccation Cracking of Clay Layers in Laboratory Tests
- Author
-
Kodikara, J. K., primary and Choi, X., additional
- Published
- 2006
- Full Text
- View/download PDF
5. Trade and Econimic Cooperation between Russian and Republic of Korea
- Author
-
Choi, X., primary
- Published
- 2001
- Full Text
- View/download PDF
6. The Influence Of The Reservoir Stress-Depletion Response On The Lifetime Considerations Of Well Completion Design
- Author
-
Addis, M.A., additional, Choi, X., additional, and Gunning, J., additional
- Published
- 1998
- Full Text
- View/download PDF
7. Experimental investigation of the effect of thin-wall substrates and spark timing retard on total hydrocarbon emissions during cold start for super-ultra-low-emission vehicle application.
- Author
-
Cha-Lee Myung, X. B., Simsoo Park, Han-Sang Kim, X. B., Kyoungdoug Min, X. B., and Myung-Sik Choi, X. B.
- Subjects
VEHICLES ,HYDROCARBONS ,EMISSIONS (Air pollution) ,ENGINES ,FLAME visualization ,INTERNAL combustion engine combustion -- Testing - Abstract
As the basic approach to improve the emission performance under cold start engine operation to meet stringent emission regulations, the effects of thin wall catalysts and spark timing retard on total hydrocarbon (THC) emission characteristics were investigated by engine performance and vehicle emissions tests. From this study, the effects of cell density on back pressure and engine performance were studied for thin-wall catalysts. The light-off time reduction of the thin-wall catalysts was also demonstrated through vehicle emission tests. The effect of spark timing retard from minimum spark advance for best torque on THC emission reduction under the cold-start condition was also studied quantitatively using a fast flame ionization detector and a flame visualization technique. As the spark timing is retarded, THC emission at the exhaust manifold is effectively reduced regardless of the air-fuel ratio. From flame visualization, as the spark timing is retarded, the flame propagation speed becomes slower and the duration of the main flame is longer. It was also found that the reduction in THC emission at the beginning of the engine start is essential to meet the more stringent emission regulations. As a result, the adoption of a high-cell-density catalyst (900 cells/2.0 mil) and the spark timing retard technique (spark advance retard case, after top dead centre 8° crank angle) makes it possible to meet the super-ultra-low-emission vehicle emission regulation if effectively combined along with a metallic catalyst and exhaust gas-flow-optimized exhaust manifold. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
8. Disease progression in Parkinson's disease patients with mild cognitive impairment: 5-year longitudinal study from the early Parkinson's disease longitudinal Singapore (PALS) cohort.
- Author
-
Deng X, Saffari SE, Xiao B, Ng SYE, Chia N, Choi X, Heng DL, Xu Z, Tay KY, Au WL, Tan EK, and Tan LC
- Subjects
- Humans, Male, Female, Longitudinal Studies, Aged, Middle Aged, Singapore epidemiology, Severity of Illness Index, Parkinson Disease physiopathology, Parkinson Disease complications, Parkinson Disease psychology, Cognitive Dysfunction physiopathology, Disease Progression
- Abstract
Aim: To investigate motor, non-motor and cognitive progression in early Parkinson's disease (PD) patients with Mild Cognitive Impairment (MCI)., Methods: PD patients were recruited within 1 year of diagnosis and were classified into PD-MCI group and PD with normal cognition (PD-NC) group. H&Y staging scale, MDS-UPDRS part III were used to assess disease severity and motor progression. Non-motor symptom scale (NMSS) was used to evaluate the NMS progression. Cognitive progression was assessed from 5 cognitive domains. Annual progression changes in the longitudinal outcomes were examined via linear mixed model with random intercept effect. False discovery rate (FDR) method was performed to control for multiple testing comparison and q-value was calculated. We set the threshold of q-values as 0.1., Result: A total of 205 PD patients, including 107 PD-MCI and 98 PD-NC patients were assessed prospectively over a 5-year period. PD-MCI patients, compared to PD-NC group, had a significantly higher progression rate in H&Y score (0.11 vs. 0.06, p=0.03, q=0.08), MDS-UPDRS motor score (3.11 vs. 1.90 p<0.001, q=0.06) and postural instability gait difficulty (PIGD) score (0.40 vs. 0.20, p=0.02, q=0.07). PD-MCI group also exhibited significantly faster deterioration in NMSS perceptual domain (PD-MCI vs. PD-NC: 0.38 vs. -0.04, p=0.01, q=0.06) and cognitive visuospatial domain (PD-MCI vs. PD-NC: 0.13 vs. -0.06, p=0.048, q=0.09) after adjustment for confounders and multiple comparisons., Conclusions: PD-MCI patients had faster decline in motor functions, visuo-perceptual and visuospatial performance. These findings provide a more comprehensive prognosis of PD-MCI, which could be helpful for clinician to manage PD-MCI patients.
- Published
- 2024
- Full Text
- View/download PDF
9. Disease Progression of Data-Driven Subtypes of Parkinson's Disease: 5-Year Longitudinal Study from the Early Parkinson's Disease Longitudinal Singapore (PALS) Cohort.
- Author
-
Deng X, Saffari SE, Xiao B, Ng SYE, Chia N, Choi X, Heng DL, Ng E, Xu Z, Tay KY, Au WL, Tan EK, and Tan LCS
- Subjects
- Humans, Male, Female, Longitudinal Studies, Middle Aged, Singapore epidemiology, Aged, Severity of Illness Index, Cognitive Dysfunction etiology, Cognitive Dysfunction physiopathology, Cognitive Dysfunction diagnosis, Parkinson Disease complications, Parkinson Disease physiopathology, Disease Progression
- Abstract
Background: The detailed trajectory of data-driven subtypes in Parkinson's disease (PD) within Asian cohorts remains undisclosed., Objective: To evaluate the motor, non-motor symptom (NMS) progression among the data-driven PD clusters., Methods: In this 5-year longitudinal study, NMS scale (NMSS), Hospital Anxiety Depression Scale (HADS), and Epworth sleepiness scale (ESS) were carried out annually to monitor NMS progression. H& Y staging scale, MDS-UPDRS part III motor score, and postural instability gait difficulty (PIGD) score were assessed annually to evaluate disease severity and motor progression. Five cognitive standardized scores were used to assess detailed cognitive progression. Linear mixed model was performed to assess the annual progression rates of the longitudinal outcomes., Results: Two hundred and six early PD patients, consisting of 43 patients in cluster A, 98 patients in cluster B and 65 subjects in cluster C. Cluster A (severe subtype) had significantly faster progression slope in NMSS Domain 3 (mood/apathy) score (p = 0.01), NMSS Domain 4 (perceptual problems) score (p = 0.02), NMSS Domain 7 (urinary) score (p = 0.03), and ESS Total Score (p = 0.04) than the other two clusters. Cluster A also progressed significantly in PIGD score (p = 0.04). For cognitive outcomes, cluster A deteriorated significantly in visuospatial domain (p = 0.002), while cluster C (mild subtype) deteriorated significantly in executive domain (p = 0.04)., Conclusions: The severe cluster had significantly faster progression, particularly in mood and perceptual NMS domains, visuospatial cognitive performances, and postural instability gait scores. Our findings will be helpful for clinicians to stratify and pre-emptively manage PD patients by developing intervention strategies to counter the progression of these domains.
- Published
- 2024
- Full Text
- View/download PDF
10. Identifying clinical features and blood biomarkers associated with mild cognitive impairment in Parkinson disease using machine learning.
- Author
-
Deng X, Ning Y, Saffari SE, Xiao B, Niu C, Ng SYE, Chia N, Choi X, Heng DL, Tan YJ, Ng E, Xu Z, Tay KY, Au WL, Ng A, Tan EK, Liu N, and Tan LCS
- Subjects
- Humans, Cross-Sectional Studies, Neuropsychological Tests, Mental Status and Dementia Tests, Parkinson Disease psychology, Cognitive Dysfunction psychology
- Abstract
Background and Purpose: A broad list of variables associated with mild cognitive impairment (MCI) in Parkinson disease (PD) have been investigated separately. However, there is as yet no study including all of them to assess variable importance. Shapley variable importance cloud (ShapleyVIC) can robustly assess variable importance while accounting for correlation between variables. Objectives of this study were (i) to prioritize the important variables associated with PD-MCI and (ii) to explore new blood biomarkers related to PD-MCI., Methods: ShapleyVIC-assisted variable selection was used to identify a subset of variables from 41 variables potentially associated with PD-MCI in a cross-sectional study. Backward selection was used to further identify the variables associated with PD-MCI. Relative risk was used to quantify the association of final associated variables and PD-MCI in the final multivariable log-binomial regression model., Results: Among 41 variables analysed, 22 variables were identified as significantly important variables associated with PD-MCI and eight variables were subsequently selected in the final model, indicating fewer years of education, shorter history of hypertension, higher Movement Disorder Society-Unified Parkinson's Disease Rating Scale motor score, higher levels of triglyceride (TG) and apolipoprotein A1 (ApoA1), and SNCA rs6826785 noncarrier status were associated with increased risk of PD-MCI (p < 0.05)., Conclusions: Our study highlighted the strong association between TG, ApoA1, SNCA rs6826785, and PD-MCI by machine learning approach. Screening and management of high TG and ApoA1 levels might help prevent cognitive impairment in early PD patients. SNCA rs6826785 could be a novel therapeutic target for PD-MCI. ShapleyVIC-assisted variable selection is a novel and robust alternative to traditional approaches for future clinical study to prioritize the variables of interest., (© 2023 European Academy of Neurology.)
- Published
- 2023
- Full Text
- View/download PDF
11. Microstructure of Brain Nuclei in Early Parkinson's Disease: Longitudinal Diffusion Kurtosis Imaging.
- Author
-
Welton T, Hartono S, Shih YC, Lee W, Chai PH, Chong SL, Ng SYE, Chia NSY, Choi X, Heng DL, Tan EK, Tan LCS, and Chan LL
- Subjects
- Humans, Female, Male, Gray Matter pathology, Case-Control Studies, Diffusion Tensor Imaging methods, Magnetic Resonance Imaging, Diffusion Magnetic Resonance Imaging methods, Parkinson Disease
- Abstract
Background: Diffusion kurtosis imaging provides in vivo measurement of microstructural tissue characteristics and could help guide management of Parkinson's disease., Objective: To investigate longitudinal diffusion kurtosis imaging changes on magnetic resonance imaging in the deep grey nuclei in people with early Parkinson's disease over two years, and whether they correlate with disease progression., Methods: We conducted a longitudinal case-control study of early Parkinson's disease. 262 people (Parkinson's disease: n = 185, aged 67.5±9.1 years; 43% female; healthy controls: n = 77, aged 66.6±8.1 years; 53% female) underwent diffusion kurtosis imaging and clinical assessment at baseline and two-year timepoints. We automatically segmented five nuclei, comparing the mean kurtosis and other diffusion kurtosis imaging indices between groups and over time using repeated-measures analysis of variance, and Pearson correlation with the two-year change in Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III., Results: At baseline, mean kurtosis was higher in Parkinson's disease than controls in the substantia nigra, putamen, thalamus and globus pallidus when adjusting for age, sex, and levodopa equivalent daily dose (p < 0.027). These differences grew over two years, with mean kurtosis increasing for the Parkinson's disease group while remaining stable for the control group; evident in significant "group ×time" interaction effects for the putamen, thalamus and globus pallidus (ηp2= 0.08-0.11, p < 0.015). However, we did not detect significant correlations between increasing mean kurtosis and declining motor function in the Parkinson's disease group., Conclusion: Diffusion kurtosis imaging of specific grey matter structures shows abnormal microstructure in PD at baseline and abnormal progression in PD over two years.
- Published
- 2023
- Full Text
- View/download PDF
12. Poor sleep quality is associated with fatigue and depression in early Parkinson's disease: A longitudinal study in the PALS cohort.
- Author
-
Koh MRE, Chua CY, Ng SY, Chia NS, Saffari SE, Chen RY, Choi X, Heng DL, Neo SX, Tay KY, Au WL, Tan EK, Tan LC, and Xu Z
- Abstract
Background: Sleep disorders are common in Parkinson's disease (PD). However, the longitudinal relationship between sleep quality and the other non-motor symptoms of PD has not been well characterized, especially in early PD., Objective: To explore the value of baseline sleep quality in predicting the progression of other non-motor symptoms in early PD., Methods: 109 early PD patients were recruited to the study. Patients were stratified into good and poor sleepers using the Pittsburgh Sleep Quality Index (PSQI). Assessments performed at baseline and 1 year follow-up included the Epworth Sleepiness Scale, Fatigue Severity Scale, Non-Motor Symptom Scale, Geriatric Depression Scale, Hospital Anxiety and Depression Scale, Apathy Scale, Montreal Cognitive Assessment and detailed neuropsychological assessments. Multivariable linear regression was performed at baseline to investigate differences in clinical scores between poor and good sleepers, while multivariable regression models were used to investigate associations between sleep quality and progression of test scores at 1 year follow-up., Results: 59 poor sleepers and 50 good sleepers were identified. At baseline, poor sleepers had greater HADS anxiety scores ( p = 0.013) [2.99 (95% CI 2.26, 3.73)] than good sleepers [1.59 (95% CI 0.75, 2.42)]. After 1 year, poor sleepers had greater fatigue (FSS scores +3.60 as compared to -2.93 in good sleepers, p = 0.007) and depression (GDS scores +0.42 as compared to -0.70, p = 0.006)., Conclusion: This study shows a longitudinal association between sleep quality, fatigue, and depression in early PD patients, independent of medication effect and disease severity, this may support the hypothesis that a common serotonergic pathway is implicated in these non-motor symptoms., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Koh, Chua, Ng, Chia, Saffari, Chen, Choi, Heng, Neo, Tay, Au, Tan, Tan and Xu.)
- Published
- 2022
- Full Text
- View/download PDF
13. Biomarker characterization of clinical subtypes of Parkinson Disease.
- Author
-
Deng X, Saffari SE, Liu N, Xiao B, Allen JC, Ng SYE, Chia N, Tan YJ, Choi X, Heng DL, Lo YL, Xu Z, Tay KY, Au WL, Ng A, Tan EK, and Tan LCS
- Abstract
The biological underpinnings of the PD clusters remain unknown as the existing PD clusters lacks biomarker characterization. We try to identify clinical subtypes of Parkinson Disease (PD) in an Asian cohort and characterize them by comparing clinical assessments, genetic status and blood biochemical markers. A total of 206 PD patients were included from a multi-centre Asian cohort. Hierarchical clustering was performed to generate PD subtypes. Clinical and biological characterization of the subtypes were performed by comparing clinical assessments, allelic distributions of Asian related PD gene (SNCA, LRRK2, Park16, ITPKB, SV2C) and blood biochemical markers. Hierarchical clustering method identified three clusters: cluster A (severe subtype in motor, non-motor and cognitive domains), cluster B (intermediate subtype with cognitive impairment and mild non-motor symptoms) and cluster C (mild subtype and young age of onset). The three clusters had significantly different allele frequencies in two SNPs (Park16 rs6679073 A allele carriers in cluster A B C: 67%, 74%, 89%, p = 0.015; SV2C rs246814 T allele distribution: 7%, 12%, 25%, p = 0.026). Serum homocysteine (Hcy) and C-reactive protein (CRP) levels were also significantly different among three clusters (Mean levels of Hcy and CRP among cluster A B C were: 19.4 ± 4.2, 18.4 ± 5.7, 15.6 ± 5.6, adjusted p = 0.005; 2.5 ± 5.0, 1.5 ± 2.4, 0.9 ± 2.1, adjusted p < 0.0001, respectively). Of the 3 subtypes identified amongst early PD patients, the severe subtype was associated with significantly lower frequency of Park16 and SV2C alleles and higher levels of Hcy and CRP. These biomarkers may be useful to stratify PD subtypes and identify more severe subtypes., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
14. Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson's Disease.
- Author
-
Tan YJ, Saffari SE, Zhao Y, Ng EYL, Yong ACW, Ng SYE, Chia NSY, Choi X, Heng D, Neo S, Xu Z, Tay KY, Au WL, Tan EK, Tan LCS, and Ng ASL
- Subjects
- Executive Function, Genetic Predisposition to Disease, Humans, Longitudinal Studies, Polymorphism, Genetic, Parkinson Disease complications, Parkinson Disease genetics, alpha-Synuclein genetics
- Abstract
The alpha-synuclein gene promoter (SNCA-Rep1) is associated with Parkinson's disease (PD), but its relationship with performance across individual cognitive domains in early PD is unknown. This study aims to investigate Rep1 polymorphism and longitudinal change in cognition in early PD. In this longitudinal study, Rep1 allele lengths ("long" and "short") were determined in 204 early PD patients. All participants underwent annual neuropsychological assessments and followed up for 3 years. Linear-mixed model was performed to investigate the association of Rep1 status and longitudinal change in individual cognitive domains. At 3 years, significant decline in executive function was observed in long Rep1 allele carriers vs short allele carriers, controlling for potential confounders. This is the first longitudinal study demonstrating that long Rep1 allele carriers are at higher risk for executive dysfunction in early PD.
- Published
- 2022
- Full Text
- View/download PDF
15. Plasma Neurofilament Light Concentration Is Associated with Diffusion-Tensor MRI-Based Measures of Neurodegeneration in Early Parkinson's Disease.
- Author
-
Welton T, Tan YJ, Saffari SE, Ng SYE, Chia NSY, Yong ACW, Choi X, Heng DL, Shih YC, Hartono S, Lee W, Xu Z, Tay KY, Au WL, Tan EK, Chan LL, Ng ASL, and Tan LCS
- Subjects
- Biomarkers, Humans, Intermediate Filaments, Magnetic Resonance Imaging, Neurofilament Proteins, Diffusion Tensor Imaging methods, Parkinson Disease complications, Parkinson Disease diagnostic imaging
- Abstract
Background: Neurofilament light is a marker of axonal degeneration, whose measurement from peripheral blood was recently made possible by new assays., Objective: We aimed to determine whether plasma neurofilament light chain (NfL) concentration reflects brain white matter integrity in patients with early Parkinson's disease (PD)., Methods: 137 early PD patients and 51 healthy controls were included. Plasma NfL levels were measured using ultrasensitive single molecule array. 3T MRI including diffusion tensor imaging was acquired for voxelwise analysis of association between NfL and both fractional anisotropy (FA) and mean diffusivity (MD) in white matter tracts and subcortical nuclei., Results: A pattern of brain microstructural changes consistent with neurodegeneration was associated with increased plasma NfL in most of the frontal lobe and right internal capsule, with decreased FA and increased MD. The same clusters were also associated with poorer global cognition. A significant cluster in the left putamen was associated with increased NfL, with a significantly greater effect in PD than controls., Conclusion: Plasma NfL may be associated with brain microstructure, as measured using diffusion tensor imaging, in patients with early PD. Higher plasma NfL was associated with a frontal pattern of neurodegeneration that also correlates with cognitive performance in our cohort. This may support a future role for plasma NfL as an accessible biomarker for neurodegeneration and cognitive dysfunction in PD.
- Published
- 2022
- Full Text
- View/download PDF
16. Blood Lipid Biomarkers in Early Parkinson's Disease and Parkinson's Disease with Mild Cognitive Impairment.
- Author
-
Deng X, Saffari SE, Ng SYE, Chia N, Tan JY, Choi X, Heng DL, Xu Z, Tay KY, Au WL, Liu N, Ng A, Tan EK, and Tan LCS
- Subjects
- Apolipoprotein A-I, Apolipoproteins B, Biomarkers, Cholesterol, HDL, Cholesterol, LDL, Humans, Lipids, Triglycerides, Cognitive Dysfunction diagnosis, Cognitive Dysfunction etiology, Parkinson Disease complications, Parkinson Disease diagnosis
- Abstract
Background: Lipid biomarkers have potential neuroprotective effects in Parkinson's disease (PD) and there is limited evidence in the field., Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and PD., Methods: A total of 205 PD patients and 102 non-PD subjects were included from Early Parkinson's disease Longitudinal Singapore (PALS) cohort. We investigated 6 serum lipid biomarkers including total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (Apo A1), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B). PD patients were further classified into mild cognitive impairment (MCI) and normal cognition (NC) subgroups. We conducted a cross-sectionals study to examine the association between lipids and PD and further explored the relationship between lipids and PD-MCI., Results: PD patients had significantly lower level of lipid panel including TC, TG, HDL-C, Apo A1, LDL-C, and Apo B (all p < 0.05). TC, TG, Apo A1, and Apo B levels were independent protective factors (p < 0.05) for PD in the logistic regression model. PD-MCI group had significantly higher mean TC, TG, and Apo A1 levels compared to PD-NC group. Higher TC, TG, and Apo A1 levels were independent risk factors (p < 0.05) for PD-MCI., Conclusion: We demonstrated that PD patients had significantly lower levels of lipid biomarkers while PD-MCI patients had higher levels of TC, TG, and Apo A1. TC, TG, and Apo A1 may be useful biomarkers for PD-MCI.
- Published
- 2022
- Full Text
- View/download PDF
17. Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease.
- Author
-
Kohat AK, Ng SYE, Wong ASY, Chia NSY, Choi X, Heng DL, Li W, Ng HL, Chua ST, Neo SXM, Xu Z, Tay KY, Au WL, Tan EK, and Tan LCS
- Abstract
Background: Various classifications have been proposed to subtype Parkinson's disease (PD) based on their motor phenotypes. However, the stability of these subtypes has not been properly evaluated. Objective: The goal of this study was to understand the distribution of PD motor subtypes, their stability over time, and baseline factors that predicted subtype stability. Methods: Participants ( n = 170) from two prospective cohorts were included: the Early PD Longitudinal Singapore (PALS) study and the National Neuroscience Institute Movement Disorders Database. Early PD patients were classified into tremor-dominant (TD), postural instability and gait difficulty (PIGD), and indeterminate subtypes according to the Movement Disorder Society's Unified PD Rating Scale (MDS-UPDRS) criteria and clinically evaluated for three consecutive years. Results: At baseline, 60.6% patients were TD, 12.4% patients were indeterminate, and 27.1% patients were PIGD subtypes ( p < 0.05). After 3 years, only 62% of patients in TD and 50% of patients in PIGD subtypes remained stable. The mean levodopa equivalent daily dose (LEDD) was higher in the PIGD subtype (276.92 ± 232.91 mg; p = 0.01). Lower LEDD [ p < 0.05, odds ratio (OR) 0.99, 95% confidence interval (CI): 0.98-0.99] and higher TD/PIGD ratios ( p < 0.05, OR 1.77, 95% CI: 1.29-2.43) were independent predictors of stability of TD subtype with an area under the curve (AUC) of 0.787 (95%CI: 0.669-0.876), sensitivity = 57.8%, and specificity = 89.7%. Conclusion: Only 50-62% of PD motor subtypes as defined by MDS-UPDRS remained stable over 3 years. TD/PIGD ratio and baseline LEDD were independent predictors for TD subtype stability over 3 years., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Kohat, Ng, Wong, Chia, Choi, Heng, Li, Ng, Chua, Neo, Xu, Tay, Au, Tan and Tan.)
- Published
- 2021
- Full Text
- View/download PDF
18. Physical Activity Improves Anxiety and Apathy in Early Parkinson's Disease: A Longitudinal Follow-Up Study.
- Author
-
Ng SY, Chia NS, Abbas MM, Saffari ES, Choi X, Heng DL, Xu Z, Tay KY, Au WL, Tan EK, and Tan LC
- Abstract
Objective: In a prospective study, we investigated the association between physical activity and various motor, non-motor outcomes, and quality of life in early Parkinson's disease (PD) participants in the PD Longitudinal Singapore Study. Background: Prospective studies that examined the association between physical activity and motor and non-motor domains in early PD are lacking. Methods: 121 PD participants were followed-up prospectively to evaluate the association of physical activity with various symptom domains. The Physical Activity Scale for the Elderly (PASE) was used to measure physical activity annually. PD-related symptoms were categorized by motor, non-motor, and quality of life measures. Multivariate regression with gain score analysis was performed to understand the association of baseline PASE scores with the change of each variable at 1-year follow-up. Results: Higher baseline PASE scores (greater activity) were associated with a younger age, lower MDS-UPDRS motor scores, a smaller levodopa equivalent daily dose, better attention and memory scores, and better QoL. Activity scores in early PD declined on follow-up. Multivariate analysis revealed higher baseline physical activity to be associated with decreased anxiety and apathy scores at 1-year follow-up, after adjusting for demographic variables and medications. Conclusion: We demonstrated that higher baseline physical activity was associated with improved anxiety and apathy symptoms in early PD over a 1-year period., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Ng, Chia, Abbas, Saffari, Choi, Heng, Xu, Tay, Au, Tan and Tan.)
- Published
- 2021
- Full Text
- View/download PDF
19. Subjective cognitive Complaints in early Parkinson's disease patients with normal cognition are associated with affective symptoms.
- Author
-
Chua CY, Koh MRE, Chia NS, Ng SY, Saffari SE, Wen MC, Chen RY, Choi X, Heng DL, Neo SX, Tay KY, Au WL, Tan EK, Tan LC, and Xu Z
- Subjects
- Affective Symptoms epidemiology, Affective Symptoms etiology, Aged, Cognitive Dysfunction epidemiology, Cognitive Dysfunction etiology, Female, Humans, Male, Middle Aged, Parkinson Disease complications, Parkinson Disease epidemiology, Affective Symptoms physiopathology, Cognitive Dysfunction physiopathology, Diagnostic Self Evaluation, Parkinson Disease physiopathology
- Abstract
Introduction: Subjective cognitive complaints (SCC) and affective symptoms are highly prevalent in Parkinson's Disease (PD). In early PD, SCC prevalence and its affective correlates, using recommended Movement Disorders Society (MDS) Level II Criteria to define the underlying cognitive impairment, has not been previously explored., Methods: We recruited 121 participants with early PD from two tertiary hospitals in Singapore. The presence of SCC was defined using a Non-Motor Symptoms Scale Domain-5 Score ≥1. Comprehensive neuropsychological testing was conducted with Mild Cognitive Impairment (PD-MCI) defined using recommended MDS Level II Criteria. Affective symptoms were assessed using the Hospital Anxiety Depression Scale (HADS), Geriatric Depression Scale (GDS) and Apathy Scale (AS). Analysis using multivariable linear regression model was performed., Results: In our early PD cohort, SCC prevalence independent of underlying cognitive status was 38.8%. Prevalence of SCC in cognitively impaired and cognitively normal participants was 10.7% and 28.1% respectively (р = 0.241). In cognitively normal PD participants, multivariable linear regression analysis revealed that SCC was significantly associated with anxiety (β = 0.28, 95% CI = 0.09-0.79, p = 0.014), depression (β = 0.31, 95% CI = 0.10-0.59, p = 0.006) and apathy (β = 0.32, 95% CI = 1.15-5.98, p = 0.004). Such an association was not found in cognitively impaired PD participants., Conclusion: SCC is highly prevalent even in early PD. Its implications in early PD differ depending on underlying cognitive status. SCC in cognitively impaired participants underestimates the true prevalence of PD-MCI. In contrast, SCC in cognitively normal participants is suggestive of an underlying affective disorder., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson's disease.
- Author
-
Yong AC, Tan YJ, Zhao Y, Lu Z, Ng EY, Ng SY, Chia NS, Choi X, Heng D, Neo S, Xu Z, Tay KY, Au WL, Tan EK, Tan LC, and Ng AS
- Subjects
- Aged, Cross-Sectional Studies, Depression etiology, Female, Humans, Male, Middle Aged, Parkinson Disease complications, Time Factors, Microsatellite Repeats genetics, Parkinson Disease genetics, alpha-Synuclein genetics
- Abstract
Long alpha-synuclein gene (SNCA) promoter (Rep1) allele-carriers are linked to higher risk for Parkinson's disease (PD) and faster motor progression. Non-motor symptoms including autonomic, neuropsychiatric, and sleep disorders are common in PD. However, the relationship between SNCA Rep1 microsatellite lengths and non-motor symptoms in early PD remains to be elucidated. 171 consecutive early PD patients were recruited from tertiary clinics and genotyped for Rep1. Multivariable regression analyses were performed to examine associations between Rep1 alleles and non-motor outcome scores. Longer Rep1 alleles significantly associated with higher total Non-Motor Symptom Scale (NMSS) scores ( p =.006) and Hospital Anxiety and Depression Scale (HADS) depression subscale scores ( p =.002), after adjusting for covariates and Bonferroni correction. We demonstrated that SNCA Rep1 allele length influences overall non-motor symptom burden and depression in early PD patients. Further functional studies to evaluate the role of Rep1 in non-dopaminergic systems may unravel new therapeutic targets for non-motor symptoms in PD.
- Published
- 2020
- Full Text
- View/download PDF
21. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
- Author
-
Ng ASL, Tan YJ, Yong ACW, Saffari SE, Lu Z, Ng EY, Ng SYE, Chia NSY, Choi X, Heng D, Neo S, Xu Z, Keong NCH, Tay KY, Au WL, Tan LCS, and Tan EK
- Subjects
- Cognition physiology, Disease Progression, Female, Gait Disorders, Neurologic complications, Gait Disorders, Neurologic metabolism, Humans, Male, Middle Aged, Parkinson Disease metabolism, Parkinson Disease physiopathology, Prognosis, Tremor complications, Biomarkers blood, Gait physiology, Gait Disorders, Neurologic diagnosis, Intermediate Filaments metabolism, Parkinson Disease diagnosis
- Abstract
Background: The main motor subtypes of Parkinson's disease (PD) include tremor-dominant (TD) and postural instability gait disorder (PIGD), with varying disease course that warrant the development of biomarkers capable of predicting progression according to motor subtype. The PIGD subtype is associated with a poorer prognosis, hence identification of a biomarker associated with PIGD is clinically relevant. Neurofilament light (NfL) chain is a potential biomarker of disease severity in neurological disorders including PD. However, no study has investigated NfL and PD motor subtypes. Here, we aimed to investigate the diagnostic and prognostic utility of plasma NfL for PD motor subtypes in early Parkinson's disease. Given the higher risk for cognitive and motor decline in PIGD, we hypothesized that plasma NfL is a potential biomarker for PIGD., Methods: Plasma NfL was measured in 199 participants (149 PD and 50 healthy controls, HC) using an ultrasensitive single molecule array. Patients were classified into TD or PIGD based on MDS-UPDRS components. After 2 years, 115 patients were reassessed. Association between NfL and clinical measures in PIGD and TD at baseline and at 2-year follow-up were analysed., Results: At baseline, plasma NfL levels were higher in PD than HC (8.8 ± 3.4 vs 16.2 ± 7.6 pg/ml, p < 0.0001), and differentiated PD from HC with a good diagnostic accuracy (AUC = 0.833, p < 0.001). At 2 years, NfL was higher in PIGD than TD (18.4 ± 14.5 vs 12.6 ± 4.4 pg/ml, p = 0.039). Within the PIGD group, higher NfL associated significantly with worse global cognition and UPDRS motor scores at baseline, and was able to predict motor and cognitive decline at a mean follow-up duration of 1.9 years, controlled for age, sex and disease duration., Conclusions: In this longitudinal study, we demonstrated for the first time the potential utility of plasma NfL as a diagnostic and prognostic biomarker in PIGD even at early stages of PD. These important novel findings will require further confirmation in larger, longitudinal PD cohorts.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.